Gyre Therapeutics Inc. (GYRE)

Gyre Therapeutics Inc. (GYRE) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $717M; returns 1 day -0.2%, 1 week -3.8%, 1 year -28.9%.

Gyre Therapeutics Inc. (GYRE) is a clinical-stage biopharmaceutical company focused on developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs for organ fibrosis. Gyre operates with a unique business model, focusing on bringing drugs to market in China and then duplicating the process in the United States.

Groups GYRE belongs to

• Shrinking Share Count
• Biotechnology
• Biopharmaceutical
• Fibrosis
• Clinical Stage Biopharma
• Pharmaceuticals
• China Market
• China Healthcare
• Commercial Stage Biotech
• Healthcare

GYRE financial model: income statement, cash flow and balance sheet